|
101
|
314
|
4ckjA |
Crystal structure of ret tyrosine kinase domain bound to adenosine |
|
100
|
308
|
4cljA |
Structure of l1196m mutant human anaplastic lymphoma kinase in complex with pf-06463922 ((10r)-7-amino-12-fluoro-2,10,16-trimethyl- 15-oxo-10,15,16,17-tetrahydro-2h-8,4-(metheno)pyrazolo(4,3-h)(2,5,11) benzoxadiazacyclotetradecine-3-carbonitrile). |
|
85
|
273
|
6m9hA |
Jak2 jh2 in complex with diaminopyrimidine jak040 |
|
88
|
287
|
6hd6A |
Abl1 in complex with compound6 and imatinib (sti-571) |
|
102
|
303
|
6gqmA |
Crystal structure of human c-kit kinase domain in complex with a small molecule inhibitor, azd3229 |
|
101
|
298
|
6gqpA |
Crystal structure of human kdr (vegfr2) kinase domain in complex with azd3229-analogue (compound 23) |
|
101
|
305
|
6gqjA |
Crystal structure of human c-kit kinase domain in complex with azd3229-analogue (compound 18) |
|
103
|
305
|
6gqqA |
Crystal structure of human kdr (vegfr2) kinase domain in complex with azd3229-analogue (compound 35) |
|
96
|
313
|
6gwrA |
Structure of the kinase domain of human ddr1 in complex with a potent and selective inhibitor of ddr1 and ddr2 |
|
98
|
305
|
6gqkA |
Crystal structure of human c-kit kinase domain in complex with azd3229-analogue (compound 23) |
|
101
|
304
|
6gqlA |
Crystal structure of human c-kit kinase domain in complex with azd3229-analogue (compound 35) |
|
101
|
308
|
6gqoA |
Crystal structure of human kdr (vegfr2) kinase domain in complex with azd3229-analogue (compound 18) |
|
94
|
291
|
6glbA |
Crystal structure of jak3 in complex with compound 20 (fm484) |
|
99
|
298
|
6gi6A |
Crystal structure of the acvr1 (alk2) kinase in complex with a quinazolinone based alk2 inhibitor with a 5-methyl core. |
|
97
|
296
|
6gipA |
Crystal structure of the acvr1 (alk2) kinase in complex with a quinazolinone based alk2 inhibitor with a 2, 5-dimethyl core. |
|
97
|
292
|
6gl9A |
Crystal structure of jak3 in complex with compound 10 (fm475) |
|
99
|
296
|
6ginA |
Crystal structure of the acvr1 (alk2) kinase in complex with an quinazolinone based alk2 inhibitor with a 4-morpholinophenyl solvent accessible group. |
|
93
|
291
|
6glaA |
Crystal structure of jak3 in complex with compound 11 (fm481) |
|
84
|
311
|
6fu5A |
Structure of the kinase domain of human ripk2 in complex with the inhibitor cslp18 |
|
90
|
288
|
6fnhA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with a pyrazolo[3,4-d]pyrimidine fragment of nvp-bhg712 |
|
90
|
286
|
6fnkA |
Crystal structure of ephrin b4 (ephb4) receptor protein kinase with a pyrazolo[3,4-d]pyrimidine fragment of nvp-bhg712 |
|
85
|
282
|
6fnmA |
Crystal structure of ephrin b4 (ephb4) receptor protein kinase with dasatinib |
|
84
|
283
|
6fniA |
Crystal structure of ephrin b4 (ephb4) receptor protein kinase with nvp-bhg712 |
|
78
|
282
|
6fnjA |
Crystal structure of ephrin b4 (ephb4) receptor protein kinase with an isomer of nvp-bhg712 |
|
84
|
299
|
6fngA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with an isomer of nvp-bhg712 |
|
82
|
282
|
6fnlA |
Crystal structure of ephrin b4 (ephb4) receptor protein kinase |
|
88
|
289
|
6fnfA |
Crystal structure of ephrin a2 (epha2) receptor protein kinase with nvp-bhg712 |
|
85
|
296
|
6fekA |
Oncogenic point mutation of ret receptor tyrosine kinase |
|
90
|
263
|
6ep9A |
Crystal structure of btk kinase domain complexed with n-[2-methyl-3-[4-methyl-6-[4-(4-methylpiperazine-1-carbonyl)anilino]-5-oxo-pyrazin-2-yl]phenyl]-4-(1-piperidyl)benzamide |
|
96
|
295
|
6f3gA |
Irak4 in complex with inhibitor |
|
97
|
295
|
6f3gB |
Irak4 in complex with inhibitor |
|
85
|
294
|
6f3iA |
Irak4 in complex with inhibitor |
|
92
|
295
|
6f3eA |
Irak4 in complex with inhibitor |
|
96
|
295
|
6f3dA |
Irak4 in complex with inhibitor |
|
124
|
449
|
6f3fA |
Autoinhibited src kinase bound to adp |
|
90
|
312
|
6es0A |
Crystal structure of the kinase domain of human ripk2 in complex with the activation loop targeting inhibitor cs-r35 |
|
82
|
285
|
6easA |
Co-crystal of pseudokinase drik1 (drought responsive inactive kinase 1) bound to enmd-2076 |
|
100
|
312
|
6eixA |
Crystal structure of the kinase domain of the q207e mutant of acvr1 (alk2) in complex with a 2-aminopyridine inhibitor k02288 |
|
93
|
270
|
6e4fA |
Crystal structure of arq 531 in complex with the kinase domain of btk |
|
94
|
324
|
6d8eA |
Discovery of a highly potent and broadly effective egfr and her2 exon 20 insertion mutant inhibitor |
|
87
|
268
|
6di9A |
Crystal structure of btk in complex with covalent inhibitor |
|
90
|
297
|
6dkiA |
Crystal structure of trk-a in complex with the pan-trk kinase inhibitor, compound 19. |
|
89
|
290
|
6dbmA |
Tyk2 with compound 23 |
|
91
|
305
|
6dkwA |
Crystal structure of trk-a in complex with the pan-trk kinase inhibitor, compound 3. |
|
82
|
296
|
6dkbA |
Crystal structure of trk-a in complex with the pan-trk kinase inhibitor, compound 10b. |
|
86
|
288
|
6dbnA |
Jak1 with compound 23 |
|
85
|
267
|
6di3A |
Crystal structure of btk in complex with fragment ligand |
|
88
|
271
|
6di5A |
Crystal structure of btk in complex with covalent inhibitor |
|
95
|
315
|
6d20A |
Crystal structure of tyrosine-protein kinase receptor in complex with 5-(4-fluorophenyl)thieno[2,3-d]pyrimidin-4(3h)-one and 5-{[2,4-dichloro-5-(pyridin-2-yl)benzene-1-carbonyl]amino}-n-(2-hydroxy-2-methylpropyl)-1-phenyl-1h-pyrazole-3-carboxamide inhibitors |
|
91
|
295
|
6drwA |
Jak2 jh1 in complex with jnj-7706621 (crystal form 2) |
